Ardigen Joins the NVIDIA Inception Program to Accelerate AI Solutions in Life Sciences
Ardigen is excited to announce its participation in the NVIDIA Inception Program, a prestigious initiative designed to support companies at the forefront of innovation. This collaboration strengthens our commitment to harnessing AI and GPU technology to drive advancements in life sciences.
As a member of the NVIDIA Inception Program, Ardigen gains access to NVIDIA’s extensive technical expertise, advanced tools, and cutting-edge hardware. This partnership enhances our ability to deliver powerful AI solutions, especially in areas like machine learning model development, multi-omics, and single-cell analysis, using NVIDIA’s high-performance GPUs.
“We’re thrilled to be part of this program,” said Michał Warchoł,PhD MBA, CTO at Ardigen. “By integrating NVIDIA’s powerful tools into our workflows, we can further optimize our AI-driven solutions, enabling more efficient computational analysis and advancing our capabilities in life sciences research.”
Key Benefits of the NVIDIA Inception Program for Ardigen:
Advanced AI and GPU Tools: Access to industry-leading technologies like NVIDIA RAPIDS for data analysis and NVIDIA Parabricks for multi-omics, boosting the efficiency and accuracy of our solutions.
Cloud Support and Resources: With cloud credits and infrastructure resources, we can scale our computational needs while minimizing costs.
Training and Expertise: Continuous learning opportunities, including specialized workshops and training, to keep our team on the cutting edge of AI and deep learning.
Networking and Visibility: The program offers exposure to a global network of innovators, experts, and potential collaborators, helping us expand our impact in the life sciences sector.
By joining the NVIDIA Inception Program, Ardigen strengthens its position as a leader in AI innovation, committed to delivering efficient, cost-effective solutions to complex challenges in life sciences. We look forward to leveraging this partnership to further enhance our offerings and drive the future of AI in research and development.
10.01.2025
Ardigen joins the OASIS Consortium to advance multi-omics safety assessment
